Abstract
Psychologists rendering psychotherapeutic services to patients receiving pharmacological treatment with the newer antidepressants are becoming more familiar with their distinct therapeutic and side effect profiles. Increased attention has recently been directed at the sexual dysfunction associated with the use of these antidepressants. Among the newer agents, risk for the emergence of sexual side effects is greater with the selective serotonin reuptake inhibitors than with the atypical antidepressants. Psychologists who are aware of treatment-related sexual dysfunction may be more effective in collaborating with prescribing professionals to develop strategies that allow patients to minimize or better tolerate these side effects.
